Bitterman Kevin - Insider Transactions
Insider Type
individual
Companies
1
Average
1,171,488
Total Txns
24
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2023 | 0 | 11 | -11 | 0.00 | 4,673,759.31 | -4,673,759.31 |
| 2024 | 1 | 4 | -3 | 8,000,028.00 | 10,136,664.50 | -2,136,636.50 |
| 2025 | 0 | 8 | -8 | 0.00 | 5,305,269.54 | -5,305,269.54 |
| Total: | 1 | 23 | 10 | 8,000,028.00 | 20,115,693.35 | -12,115,665.35 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Gemini Therapeutics, Inc. Common Stock US36870G1058 |
61.03 USD |
2,287 Sold |
139,576 USD |
22/08/2025 | 22/08/2025 |
| Gemini Therapeutics, Inc. Common Stock US36870G1058 |
61.15 USD |
24,962 Sold |
1,526,426 USD |
13/08/2025 | 13/08/2025 |
| Gemini Therapeutics, Inc. Common Stock US36870G1058 |
60.99 USD |
7,212 Sold |
439,860 USD |
13/08/2025 | 14/08/2025 |
| Gemini Therapeutics, Inc. Common Stock US36870G1058 |
60.95 USD |
395 Sold |
24,075 USD |
05/08/2025 | 05/08/2025 |
| Gemini Therapeutics, Inc. Common Stock US36870G1058 |
61.04 USD |
8,492 Sold |
518,352 USD |
30/07/2025 | 30/07/2025 |
| Gemini Therapeutics, Inc. Common Stock US36870G1058 |
60.97 USD |
29,837 Sold |
1,819,162 USD |
23/07/2025 | 23/07/2025 |
| Gemini Therapeutics, Inc. Common Stock US36870G1058 |
61.17 USD |
13,033 Sold |
797,229 USD |
23/07/2025 | 24/07/2025 |
| Gemini Therapeutics, Inc. Common Stock US36870G1058 |
61.13 USD |
664 Sold |
40,590 USD |
18/07/2025 | 18/07/2025 |
| Gemini Therapeutics, Inc. Common Stock US36870G1058 |
36.00 USD |
222,223 Bought |
8,000,028 USD |
17/06/2024 | 17/06/2024 |
| Gemini Therapeutics, Inc. Common Stock US36870G1058 |
73.50 USD |
26,157 Sold |
1,922,540 USD |
05/03/2024 | 05/03/2024 |